文献速递免疫规划慢病防控与筛查

丹麦儿童期天花与卡介苗接种和皮肤恶性黑色素瘤的关联

Smallpox and BCG vaccination in childhood and cutaneous malignant melanoma in Danish adults followed from 18 to 49 years.
PubMed 文献 · Vaccine · 2019-09-16

该研究基于丹麦登记库的病例-队列设计,随访1965-1976年出生者至18-49岁,分析学龄前天花疫苗和学龄期卡介苗接种与皮肤恶性黑色素瘤(CMM)的关联。调整后HR为1.29(95%CI 0.72-2.31),置信区间宽,不能排除 modest 保护、无效或 modest 有害效应。

要点

  • 天花和/或卡介苗接种与CMM的调整HR为1.29(95%CI 0.72-2.31)。
  • 仅天花接种HR=1.23(95%CI 0.53-2.86),仅卡介苗HR=1.13(95%CI 0.61-2.09)。
  • 两种疫苗均接种HR=1.75(95%CI 0.87-3.48),1岁内接种结果相似。

核心结论

  • 未发现天花和卡介苗接种对年轻丹麦成人CMM有强保护作用。
  • 置信区间宽,数据可兼容 modest 保护、无效或 modest 有害效应。
  • 估计值不排斥新生儿接种的潜在 modest 有益效应。

研究设计与样本

  • 基于登记库的病例-队列研究,利用丹麦天花和卡介苗逐步停种期(1965-1976年出生)接种率下降。
  • 背景人群46,239人,随访至2014年12月31日(最大49岁),发生188例CMM,其中172例(91%)信息完整纳入分析。
  • 儿童期接种信息来自哥本哈根学校健康记录,与全国癌症、迁移和死亡登记库通过个人识别号链接。

主要发现

  • 与未接种任何疫苗者相比,接种卡介苗和/或天花疫苗者CMM调整HR=1.29(95%CI 0.72-2.31)。
  • 仅天花接种HR=1.23(95%CI 0.53-2.86),仅卡介苗接种HR=1.13(95%CI 0.61-2.09)。
  • 两种疫苗均接种HR=1.75(95%CI 0.87-3.48),1岁内接种结果相似。

临床怎么用

  • 当前证据不足以支持天花或卡介苗接种用于CMM预防。
  • 解读时应考虑宽置信区间,不能排除 modest 效应。

局限性

  • CMM病例数较少(172例分析),置信区间宽。
  • 利用历史接种率下降的自然实验,可能存在未测量混杂。
  • 接种信息来自学校健康记录,部分个体信息不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early smallpox and Bacillus Calmette-Guérin (BCG) vaccinations have been associated with reduced risk of cutaneous malignant melanoma (CMM). We assessed the association between pre-school smallpox vaccination and early-school BCG vaccination and CMM in a young Danish population. METHODS: We conducted a register-based case-cohort study of individuals growing up during the phase-out period of smallpox and BCG vaccination in Denmark (born 1965-1976) utilising the decrease in vaccination during this period. Information on childhood vaccinations and potential confounders from Copenhagen school health records were linked with nationwide registers on cancer (CMM diagnoses), migrations and deaths by personal identification numbers. RESULTS: The individuals were followed from age 18 until 31/12/2014 (maximum age at end of follow-up, 49 years). 188 cases of CMM occurred in the background population of 46,239 individuals; 172 CMM cases (91%) had full information and were analysed. The adjusted hazard ratio (HR) for CMM by BCG and/or smallpox vaccination compared with neither vaccine was 1.29 (95% confidence interval (CI) 0.72-2.31). For smallpox vaccination only, HR = 1.23 (95% CI 0.53-2.86) for BCG vaccination only, HR = 1.13 (95% CI 0.61-2.09) and for both smallpox and BCG vaccination, HR = 1.75 (95% CI 0.87-3.48) compared with none of these. Vaccination below the age of one year gave similar results. CONCLUSIONS: We found no strong beneficial effect of smallpox and BCG vaccination against CMM among young adult Danes and with broad confidence intervals our data alone could be compatible with both modest preventive effects, no effects, and modest harmful effects. Our estimates do not contradict a potential modest beneficial effect of neonatal vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Rieckmann A, Meyle KD, Rod NH, et al. Smallpox and BCG vaccination in childhood and cutaneous malignant melanoma in Danish adults followed from 18 to 49 years. Vaccine. 2019. PMID: 31537447. doi:10.1016/j.vaccine.2019.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。